Suplementación prenatal con omega 3 y su efecto en complicaciones durante el embarazo

Simple item page
dc.coverageDOI: 10.37527/2022.72.2.007
dc.creatorPeñailillo, Reyna
dc.creatorPlaza, Alejandra
dc.creatorDíaz, Claudio
dc.creatorLagos, Matías
dc.creatorBarros, Antonia
dc.creatorIllanes, Sebastián E.
dc.date2022
dc.date.accessioned2025-11-18T19:48:51Z
dc.date.available2025-11-18T19:48:51Z
dc.description<p>Effect of prenatal omega 3 supplementation on pregnancy outcomes. During pregnancy, omega 3 supplementation has raised its popularity due to evidence that it would show not only benefits in the neural and visual development of the unborn child, but also in the prevention of obstetrical pathologies associated with of perinatal morbidity and mortality. Omega 3 polyunsaturated fatty acids (PUFAs), specifically, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), possess anti-inflammatory, vasodilatory and anti-aggregating properties, which have led to the use of PUFAs in the prevention of cardiovascular diseases. In this review, we detail the effects of omega 3 supplementation on different aspects of pregnancy such as prevention of preterm birth, pre-eclampsia, postpartum depression, and improved metabolism during gestational diabetes. Although there are several randomized clinical trials using omega-3 supplementation during pregnancy, the evidence remains inconclusive, due to variability in dosage and administration time. Certainly, a greater number of high-quality studies including randomized clinical trials are necessary to determine the impact of omega 3 supplementation during pregnancy in the prevention of obstetric pathologies. Arch Latinoam Nutr 2022; 72(2): 139-145.</p>eng
dc.descriptionEffect of prenatal omega 3 supplementation on pregnancy outcomes. During pregnancy, omega 3 supplementation has raised its popularity due to evidence that it would show not only benefits in the neural and visual development of the unborn child, but also in the prevention of obstetrical pathologies associated with of perinatal morbidity and mortality. Omega 3 polyunsaturated fatty acids (PUFAs), specifically, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), possess anti-inflammatory, vasodilatory and anti-aggregating properties, which have led to the use of PUFAs in the prevention of cardiovascular diseases. In this review, we detail the effects of omega 3 supplementation on different aspects of pregnancy such as prevention of preterm birth, pre-eclampsia, postpartum depression, and improved metabolism during gestational diabetes. Although there are several randomized clinical trials using omega-3 supplementation during pregnancy, the evidence remains inconclusive, due to variability in dosage and administration time. Certainly, a greater number of high-quality studies including randomized clinical trials are necessary to determine the impact of omega 3 supplementation during pregnancy in the prevention of obstetric pathologies. Arch Latinoam Nutr 2022; 72(2): 139-145.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/5927b257-31de-4ead-bb24-ccf5ad5176c4
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/55776
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.72 (2022) nr.2 p.139-145
dc.subjectOmega 3
dc.subjectpregnancy supplementation
dc.subjectpreterm birth
dc.subjectSDG 3 - Good Health and Well-being
dc.titleSuplementación prenatal con omega 3 y su efecto en complicaciones durante el embarazospa
dc.titleEffect of prenatal omega 3 supplementation on pregnancy outcomeseng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE